US4729999A
(en)
*
|
1984-10-12 |
1988-03-08 |
Bcm Technologies |
Antiestrogen therapy for symptoms of estrogen deficiency
|
US4820736A
(en)
*
|
1987-03-20 |
1989-04-11 |
Yale University |
Use of clomiphene to predict fertility in a human female
|
US4970237A
(en)
*
|
1987-03-20 |
1990-11-13 |
Yale University |
Use of clomiphene to increase bone mass in premenopausal women
|
GB8813353D0
(en)
*
|
1988-06-06 |
1988-07-13 |
Ici Plc |
Therapeutic product
|
US5516790A
(en)
*
|
1989-01-23 |
1996-05-14 |
Texas A&M University System Technology Licensing Office |
Synthesis and application of alkyl-substituted dibenzofurans as antitumorigenic agents
|
DE3916112A1
(de)
*
|
1989-05-16 |
1990-11-22 |
Schering Ag |
Dihydrospirorenon als antiandrogen
|
US5487897A
(en)
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
US5324519A
(en)
*
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US5182266A
(en)
*
|
1990-01-31 |
1993-01-26 |
Abbott Laboratories |
Method for treating renal disease
|
US5189212A
(en)
*
|
1990-09-07 |
1993-02-23 |
University Of Georgia Research Foundation, Inc. |
Triarylethylene carboxylic acids with estrogenic activity
|
JPH04312526A
(ja)
*
|
1991-04-09 |
1992-11-04 |
Fujisawa Pharmaceut Co Ltd |
骨疾患治療剤
|
USRE38968E1
(en)
*
|
1992-07-28 |
2006-02-07 |
Eli Lilly And Company |
Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
|
USRE39049E1
(en)
*
|
1992-07-28 |
2006-03-28 |
Eli Lilly And Company |
Methods for inhibiting bone loss
|
TW366342B
(en)
*
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
IL107343A
(en)
*
|
1992-11-02 |
2003-10-31 |
Wyeth Corp |
PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
|
TW383306B
(en)
*
|
1992-12-22 |
2000-03-01 |
Lilly Co Eli |
New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
|
ES2173911T3
(es)
*
|
1992-12-29 |
2002-11-01 |
Michael F Holick |
Uso de glicosidos en vitamina d para el tratamiento o prevencion de la osteoporosis.
|
US5482949A
(en)
*
|
1993-03-19 |
1996-01-09 |
Eli Lilly And Company |
Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
|
WO1994022451A1
(en)
*
|
1993-04-07 |
1994-10-13 |
Oklahoma Medical Research Foundation |
Selective regulation of b lymphocyte precursors by hormones
|
ZA944377B
(en)
*
|
1993-06-24 |
1995-12-20 |
Lilly Co Eli |
Hypoglycemic agents
|
US5681873A
(en)
*
|
1993-10-14 |
1997-10-28 |
Atrix Laboratories, Inc. |
Biodegradable polymeric composition
|
DE4335876A1
(de)
*
|
1993-10-17 |
1995-04-20 |
Schering Ag |
Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
|
US6417198B1
(en)
|
1993-12-21 |
2002-07-09 |
Eli Lilly And Company |
Methods of inhibiting CNS problems in post-menopausal women
|
US5534526A
(en)
*
|
1993-12-21 |
1996-07-09 |
Eli Lilly And Company |
Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
|
US5478847A
(en)
|
1994-03-02 |
1995-12-26 |
Eli Lilly And Company |
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
US5650425A
(en)
*
|
1994-04-04 |
1997-07-22 |
Pharmos Corporation |
Permanently ionic derivatives of steroid hormones and their antagonists
|
US5681835A
(en)
*
|
1994-04-25 |
1997-10-28 |
Glaxo Wellcome Inc. |
Non-steroidal ligands for the estrogen receptor
|
US5637598A
(en)
*
|
1994-11-18 |
1997-06-10 |
Eli Lilly And Company |
Methods of inhibiting bone loss
|
AU712711B2
(en)
*
|
1994-11-29 |
1999-11-11 |
Hoechst Marion Roussel, Inc. |
Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
|
JPH10509962A
(ja)
*
|
1994-11-29 |
1998-09-29 |
ヘキスト・マリオン・ルセル・インコーポレイテツド |
骨粗鬆症の治療および予防におけるトリアリール−エチレン誘導体の使用方法
|
US5691384A
(en)
*
|
1994-11-29 |
1997-11-25 |
Hoechst Marion Roussel, Inc. |
Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
|
US5554600A
(en)
*
|
1995-01-20 |
1996-09-10 |
Eli Lilly And Company |
Methods for inhibiting endometriosis
|
US5489587A
(en)
*
|
1995-01-20 |
1996-02-06 |
Eli Lilly And Company |
Benzofurans used to inhibit bone loss
|
EP0722727A1
(de)
*
|
1995-01-20 |
1996-07-24 |
Eli Lilly And Company |
Benzofuran-Derivate zur Hemmung der uterinem Fibrose
|
US5861431A
(en)
*
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
US5747059A
(en)
*
|
1996-01-11 |
1998-05-05 |
Novo Nordisk A/S |
Atrophy of skin/mucous membrane
|
WO1997025035A1
(en)
*
|
1996-01-11 |
1997-07-17 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
|
HN1996000101A
(es)
|
1996-02-28 |
1997-06-26 |
Inc Pfizer |
Terapia combinada para la osteoporosis
|
KR19980049229A
(ko)
*
|
1996-12-19 |
1998-09-15 |
이대원 |
줌렌즈 광학계
|
WO1998033499A1
(en)
*
|
1997-01-29 |
1998-08-06 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for increasing libido in post-menopausal women
|
AU5749998A
(en)
*
|
1997-02-11 |
1998-08-26 |
Novo Nordisk A/S |
Methods for treatment or prophylaxis of menopausal symptoms
|
US5789443A
(en)
*
|
1997-04-25 |
1998-08-04 |
Gollobin; Charlotte |
Method for treating flushing associated with menopause
|
CA2287244A1
(en)
*
|
1997-04-25 |
1998-11-05 |
Henry Uhlman Bryant |
Indene compounds having activity as serms
|
KR100440100B1
(ko)
*
|
1997-07-25 |
2004-09-30 |
삼성테크윈 주식회사 |
리어 포커스식 소형 줌렌즈
|
NZ502738A
(en)
|
1997-08-15 |
2002-06-28 |
Univ Duke |
Triphenylethylene derivatives similar to tamoxifen or toremifene derivatives
|
US5968918A
(en)
*
|
1997-10-17 |
1999-10-19 |
Kanda; Iwao |
Method for the prevention of coronary artery spasm
|
US6255359B1
(en)
|
1997-12-23 |
2001-07-03 |
Board Of Regents Of The University Of Texas System |
Permeable compositions and methods for their preparation
|
US6187329B1
(en)
|
1997-12-23 |
2001-02-13 |
Board Of Regents Of The University Of Texas System |
Variable permeability bone implants, methods for their preparation and use
|
ES2359973T3
(es)
*
|
1998-03-19 |
2011-05-30 |
MERCK SHARP & DOHME CORP. |
Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
|
US7128927B1
(en)
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
US20040176470A1
(en)
*
|
1998-05-07 |
2004-09-09 |
Steiner Mitchell S. |
Method for treatment and chemoprevention of prostate cancer
|
US6069153A
(en)
*
|
1998-05-12 |
2000-05-30 |
American Home Products Corporation |
Indenoindoles and benzocarbazoles as estrogenic agents
|
US6479535B1
(en)
*
|
1998-05-15 |
2002-11-12 |
Wyeth |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
|
CZ299334B6
(cs)
*
|
1998-05-15 |
2008-06-25 |
Wyeth |
Farmaceutický prostredek
|
AU4701299A
(en)
*
|
1998-06-23 |
2000-01-10 |
Stuart R. Adler |
Therapeutic applications of estrogenic carboxylic acids
|
US6323190B1
(en)
|
1998-07-31 |
2001-11-27 |
The Univeristy Of Georgia Research Foundation, Inc. |
Estrogen mimetics lacking reproductive tract effects
|
HUP0200871A3
(en)
|
1999-05-04 |
2004-04-28 |
Strakan Int Ltd |
Androgen glycosides and androgenic activity thereof
|
US6159959A
(en)
*
|
1999-05-06 |
2000-12-12 |
American Home Products Corporation |
Combined estrogen and antiestrogen therapy
|
US6245812B1
(en)
|
1999-07-15 |
2001-06-12 |
Charlotte Gollobin |
Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids
|
UA75339C2
(en)
*
|
1999-08-31 |
2006-04-17 |
Schering Ag |
Use of mesoprogestins (progesterone receptor modulators) as pharmaceutical components for manufacture of medicament for hormone replacement therapy (hrt)
|
US8226598B2
(en)
*
|
1999-09-24 |
2012-07-24 |
Tolmar Therapeutics, Inc. |
Coupling syringe system and methods for obtaining a mixed composition
|
TW593256B
(en)
|
1999-11-16 |
2004-06-21 |
Hormos Medical Oy Ltd |
Triphenylalkene derivatives and their use as selective estrogen receptor modulators
|
CA2409647C
(en)
*
|
2000-05-26 |
2012-07-03 |
Harry Fisch |
Methods of treating androgen deficiency in men using selective antiestrogens
|
US6326366B1
(en)
|
2000-08-22 |
2001-12-04 |
Protein Technologies International |
Hormone replacement therapy
|
US20030216358A1
(en)
*
|
2001-07-05 |
2003-11-20 |
Muchmore Douglas Boyer |
Method for enhancing bone mineral density gain
|
US7737185B2
(en)
*
|
2001-07-09 |
2010-06-15 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene
|
WO2003005954A2
(en)
*
|
2001-07-09 |
2003-01-23 |
Zonagen, Inc. |
Methods and materials for the treatment of testosterone deficiency in men
|
US20040096510A1
(en)
*
|
2001-11-29 |
2004-05-20 |
Steiner Mitchell S. |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
US20050080143A1
(en)
*
|
2001-11-29 |
2005-04-14 |
Steiner Mitchell S. |
Treatment of androgen-deprivation induced osteoporosis
|
EP1862165A3
(de)
*
|
2001-11-29 |
2008-06-25 |
GTX, Inc. |
Verhinderung und Behandlung von durch Androgenverfall hervorgerufenen Hitzewallungen
|
US7524866B2
(en)
*
|
2001-11-29 |
2009-04-28 |
Gtx, Inc. |
Prevention and treatment of androgen—deprivation induced osteoporosis
|
US20070197664A1
(en)
*
|
2001-11-29 |
2007-08-23 |
Steiner Mitchell S |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
US20060269611A1
(en)
*
|
2001-11-29 |
2006-11-30 |
Steiner Mitchell S |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
US20040214898A1
(en)
*
|
2001-11-29 |
2004-10-28 |
Steiner Mitchell S. |
Methods for treating hot flashes
|
US20080249183A1
(en)
*
|
2001-11-29 |
2008-10-09 |
Steiner Mitchell S |
Treatment of androgen-deprivation induced osteoporosis
|
TW200306198A
(en)
*
|
2002-04-02 |
2003-11-16 |
Chugai Pharmaceutical Co Ltd |
Estrone derivative and process for producing the same
|
US20060106010A1
(en)
*
|
2003-05-27 |
2006-05-18 |
Black Larry J |
Methods for inhibiting bone loss
|
US20040248989A1
(en)
|
2003-06-05 |
2004-12-09 |
Risto Santti |
Method for the treatment or prevention of lower urinary tract symptoms
|
MX2007000050A
(es)
*
|
2004-07-14 |
2007-07-10 |
Repros Therapeutics Inc |
Trans-clomifeno para el tratamiento de hipertrofia de prostata benigna, cancer de prostata, hipogonadismo, trigliceridos elevados y colesterol elevado.
|
PL219509B1
(pl)
*
|
2005-02-04 |
2015-05-29 |
Repros Therapeutics Inc |
Zastosowanie kompozycji zawierającej trans-klomifen
|
WO2006102232A2
(en)
*
|
2005-03-22 |
2006-09-28 |
Repros Therapeutics Inc. |
Dosing regimes for trans-clomiphene
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
WO2007135547A2
(en)
*
|
2006-05-22 |
2007-11-29 |
Hormos Medical Ltd. |
Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis
|
KR20090029237A
(ko)
*
|
2006-06-02 |
2009-03-20 |
피어 트리 파머슈티칼스 인코포레이티드 |
위축성 질염을 치료하는 방법
|
US20080161324A1
(en)
*
|
2006-09-14 |
2008-07-03 |
Johansen Lisa M |
Compositions and methods for treatment of viral diseases
|
US7504530B2
(en)
*
|
2007-02-14 |
2009-03-17 |
Hormos Medical Ltd. |
Methods for the preparation of fispemifene from ospemifene
|
ES2590262T3
(es)
*
|
2007-02-14 |
2016-11-21 |
Hormos Medical Ltd. |
Método para la preparación de derivados de trifenilbuteno con valor terapéutico
|
NZ585389A
(en)
*
|
2007-10-16 |
2011-10-28 |
Repros Therapeutics Inc |
Trans-clomiphene for metabolic syndrome
|
EP2222636B1
(de)
|
2007-12-21 |
2013-04-10 |
Ligand Pharmaceuticals Inc. |
Selektive androgenrezeptormodulatoren (sarms) und ihre verwendung
|
AU2009324679A1
(en)
*
|
2008-12-09 |
2011-07-28 |
University Of Florida Research Foundation, Inc. |
Kinase inhibitor compounds
|
UA113291C2
(xx)
|
2011-08-04 |
2017-01-10 |
|
Метаболіти транскломіфену і їх застосування
|
EP2812928B1
(de)
|
2012-02-10 |
2019-04-17 |
Facebook Technologies, LLC |
Led-chip
|
WO2014060639A1
(en)
|
2012-10-19 |
2014-04-24 |
Fermion Oy |
A process for the preparation of ospemifene
|
US9687458B2
(en)
|
2012-11-02 |
2017-06-27 |
Repros Therapeutics Inc. |
Trans-clomiphene for use in cancer therapy
|
US10441567B2
(en)
|
2014-01-17 |
2019-10-15 |
Ligand Pharmaceuticals Incorporated |
Methods and compositions for modulating hormone levels
|
SG11201609050UA
(en)
|
2014-05-30 |
2016-12-29 |
Pfizer |
Carbonitrile derivatives as selective androgen receptor modulators
|
UA121971C2
(uk)
|
2014-07-24 |
2020-08-25 |
Аспен Парк Фармасутікалс, Інк. |
Лікування викликаних антиандрогенною терапією припливів та остеопорозу із застосуванням цис-кломіфену
|
WO2023275715A1
(en)
|
2021-06-30 |
2023-01-05 |
Pfizer Inc. |
Metabolites of selective androgen receptor modulators
|